scorecardresearch
Add as a preferred source on Google
Wednesday, October 1, 2025
TopicPharma sector

Topic: Pharma sector

Govt gives Rs 15,000-cr boost to API and devices industry to check shortage amid COVID-19

The government hasn’t yet announced details of the policy, which seeks to make India self-reliant in the manufacturing of bulk drugs.   

India could avert medicine shortage as bulk drugs start arriving from coronavirus-hit China

While major supply has started arriving through sea, some cargoes 'airlifted' by the government on behalf of pharma companies have also started coming in.

Is Indian economy equipped to deal with the global disruption caused by coronavirus?

The novel coronavirus or COVID-19, which has claimed 2,800 lives in China and affected more than 80,000 people worldwide, is taking a toll on global economy.

Himachal govt to file FIR against cough syrup makers ‘responsible’ for 10 infant deaths 

The Coldbest-PC cough syrup, manufactured by the Himachal-based Digital Vision firm, has allegedly led to deaths of 9 infants in J&K and one in Haryana. 

Prices of Paracetamol, other bulk drugs jump as coronavirus crisis stokes fear of shortage

The price rise won't affect consumers since pharmaceutical companies are not allowed to push up prices of key drugs by more than 10% per year.

Don’t arrange hotels, sightseeing for doctors — Modi govt’s fresh warning to pharma firms

Latest warning from Department of Pharmaceuticals follows a conference of Indian Psychiatric Society in Kolkata. Companies told to adhere to ethics code.

Coronavirus spread pushes drugmakers to hunt for ways to stop pathogen eluding travel curbs

Pharma companies are looking to re-purpose medicines developed against other lethal viruses, and relying on new technologies to develop a vaccine faster.

‘Prove or apologise’ — IMA writes to PM Modi on pharma firms bribing doctors with women

In letter to PM, IMA says it's confident there's no evidence to prove bribery allegations against doctors, accuses govt of ‘trying to divert attention from real issues’. 

Modi govt plans action against US writer who said Indian drugs are ‘flea-market quality’

In her May 2019 book Bottle of Lies, Katherine Eban accused Indian pharma firms of major lapses such as ‘toxic impurities’ and fudging data on quality control.  

Indian drugmakers aren’t losing sleep despite getting a record 23 warnings from US FDA

American drug regulator FDA has issued warning letters to India’s top firms such as Lupin, Glenmark Pharmaceuticals, Torrent Pharmaceuticals, Aurobindo & Cadila.

On Camera

Jana Sangh leader VK Malhotra brought Advani to Delhi, kept the party afloat after 1984 setback

Unlike his colleagues from the time of the BJS, several of whom became governors and held other constitutional posts, Malhotra chose to lead a quiet and simple retired life after the massive 2014 victory of the BJP.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

In Nepal, young dreams of serving in Indian Army crash as Agnipath halts a centuries-old tradition

Since 1815, Nepali Gorkhas have served in Indian & British Armies, as well as in Bihar, Bengal & Assam Police. Since Agnipath scheme came in, no Nepal-domiciled Gorkha has enlisted.

Something’s hidden in the Oval Office photo of Trump, Munir, Sharif. India must look closely

What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.